Quantitative stock rating · as of 2026-11-05

Moderna, Inc. (MRNA)

Name: Moderna, Inc. (MRNA) Stock Rating: C+ (Hold)
Item: Moderna, Inc.
Rating: C+
Author: QuantHarbor

C+

Hold

QuantHarbor five-lens rating band

Standout lens: Momentum.
Main drag: Price Stability.

Price at the rating date (2026-11-05): $258.38.

The rating grades MRNA through five lenses — Quality, Valuation, Momentum, Growth Trend and Price Stability — computed from filings and market data, refreshed nightly. When data is too thin to score a lens, we withhold it instead of guessing.

See the full MRNA teardown free

Lens scores, the valuation zone, financial statement charts and the complete methodology are available with a free account. QuantHarbor is descriptive research, not investment advice.